Expression of exogenous wt-p53 does not affect normal hematopoiesis: Implications for bone marrow purging

R. Scardigli, G. Bossi, G. Blandino, M. Crescenzi, S. Soddu, A. Sacchi

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

Some gene therapy approaches for cancer treatment attempt to transduce onco-suppressor genes into tumor cells. A central problem of this strategy is the targeting of tumor cells to avoid damage to normal ones. It has been noticed that transduction of wt-p53 into a large number of cancer cells induces tumor suppression. In contrast, some observations suggest that introduction of exogenous wt-p53 into nontransformed cells does not impair proliferation. If normal bone marrow (BM) cells are not affected by wt-p53 transduction, BM purging from p53-responding leukemic cells might be achieved in vitro by delivering the wild-type onco-suppressor to all marrow cells. We undertook a series of experiments to assess whether transduction of wt-p53 into normal hematopoietic cells is harmful. Two different wt-p53-recombinant retroviruses were used to infect primary, murine BM cells. Expression of exogenous wt-p53 in these cells did not affect in vitro colony formation, and did not induce any observable effects on morphology and differentiation. In contrast, the same viruses suppressed the tumor phenotype of v-src-transformed 32D cells. These results might open the way to gene therapy approaches to leukemias with the p53 gene without the need to target specifically and uniquely the tumor cells, sparing the normal ones.

Original languageEnglish
Pages (from-to)1371-1378
Number of pages8
JournalGene Therapy
Volume4
Issue number12
Publication statusPublished - 1997

Fingerprint

Bone Marrow Purging
Hematopoiesis
Neoplasms
Bone Marrow Cells
Genetic Therapy
Oncogenic Viruses
p53 Genes
Retroviridae
Tumor Suppressor Genes
Leukemia
Cell Count
Bone Marrow

Keywords

  • Gene therapy
  • Leukemia
  • Onco-suppressor
  • Retroviral vector
  • Tumor targeting

ASJC Scopus subject areas

  • Genetics

Cite this

Expression of exogenous wt-p53 does not affect normal hematopoiesis : Implications for bone marrow purging. / Scardigli, R.; Bossi, G.; Blandino, G.; Crescenzi, M.; Soddu, S.; Sacchi, A.

In: Gene Therapy, Vol. 4, No. 12, 1997, p. 1371-1378.

Research output: Contribution to journalArticle

Scardigli, R. ; Bossi, G. ; Blandino, G. ; Crescenzi, M. ; Soddu, S. ; Sacchi, A. / Expression of exogenous wt-p53 does not affect normal hematopoiesis : Implications for bone marrow purging. In: Gene Therapy. 1997 ; Vol. 4, No. 12. pp. 1371-1378.
@article{ee957f57fa784ea68888cb7f3310f17e,
title = "Expression of exogenous wt-p53 does not affect normal hematopoiesis: Implications for bone marrow purging",
abstract = "Some gene therapy approaches for cancer treatment attempt to transduce onco-suppressor genes into tumor cells. A central problem of this strategy is the targeting of tumor cells to avoid damage to normal ones. It has been noticed that transduction of wt-p53 into a large number of cancer cells induces tumor suppression. In contrast, some observations suggest that introduction of exogenous wt-p53 into nontransformed cells does not impair proliferation. If normal bone marrow (BM) cells are not affected by wt-p53 transduction, BM purging from p53-responding leukemic cells might be achieved in vitro by delivering the wild-type onco-suppressor to all marrow cells. We undertook a series of experiments to assess whether transduction of wt-p53 into normal hematopoietic cells is harmful. Two different wt-p53-recombinant retroviruses were used to infect primary, murine BM cells. Expression of exogenous wt-p53 in these cells did not affect in vitro colony formation, and did not induce any observable effects on morphology and differentiation. In contrast, the same viruses suppressed the tumor phenotype of v-src-transformed 32D cells. These results might open the way to gene therapy approaches to leukemias with the p53 gene without the need to target specifically and uniquely the tumor cells, sparing the normal ones.",
keywords = "Gene therapy, Leukemia, Onco-suppressor, Retroviral vector, Tumor targeting",
author = "R. Scardigli and G. Bossi and G. Blandino and M. Crescenzi and S. Soddu and A. Sacchi",
year = "1997",
language = "English",
volume = "4",
pages = "1371--1378",
journal = "Gene Therapy",
issn = "0969-7128",
publisher = "Nature Publishing Group",
number = "12",

}

TY - JOUR

T1 - Expression of exogenous wt-p53 does not affect normal hematopoiesis

T2 - Implications for bone marrow purging

AU - Scardigli, R.

AU - Bossi, G.

AU - Blandino, G.

AU - Crescenzi, M.

AU - Soddu, S.

AU - Sacchi, A.

PY - 1997

Y1 - 1997

N2 - Some gene therapy approaches for cancer treatment attempt to transduce onco-suppressor genes into tumor cells. A central problem of this strategy is the targeting of tumor cells to avoid damage to normal ones. It has been noticed that transduction of wt-p53 into a large number of cancer cells induces tumor suppression. In contrast, some observations suggest that introduction of exogenous wt-p53 into nontransformed cells does not impair proliferation. If normal bone marrow (BM) cells are not affected by wt-p53 transduction, BM purging from p53-responding leukemic cells might be achieved in vitro by delivering the wild-type onco-suppressor to all marrow cells. We undertook a series of experiments to assess whether transduction of wt-p53 into normal hematopoietic cells is harmful. Two different wt-p53-recombinant retroviruses were used to infect primary, murine BM cells. Expression of exogenous wt-p53 in these cells did not affect in vitro colony formation, and did not induce any observable effects on morphology and differentiation. In contrast, the same viruses suppressed the tumor phenotype of v-src-transformed 32D cells. These results might open the way to gene therapy approaches to leukemias with the p53 gene without the need to target specifically and uniquely the tumor cells, sparing the normal ones.

AB - Some gene therapy approaches for cancer treatment attempt to transduce onco-suppressor genes into tumor cells. A central problem of this strategy is the targeting of tumor cells to avoid damage to normal ones. It has been noticed that transduction of wt-p53 into a large number of cancer cells induces tumor suppression. In contrast, some observations suggest that introduction of exogenous wt-p53 into nontransformed cells does not impair proliferation. If normal bone marrow (BM) cells are not affected by wt-p53 transduction, BM purging from p53-responding leukemic cells might be achieved in vitro by delivering the wild-type onco-suppressor to all marrow cells. We undertook a series of experiments to assess whether transduction of wt-p53 into normal hematopoietic cells is harmful. Two different wt-p53-recombinant retroviruses were used to infect primary, murine BM cells. Expression of exogenous wt-p53 in these cells did not affect in vitro colony formation, and did not induce any observable effects on morphology and differentiation. In contrast, the same viruses suppressed the tumor phenotype of v-src-transformed 32D cells. These results might open the way to gene therapy approaches to leukemias with the p53 gene without the need to target specifically and uniquely the tumor cells, sparing the normal ones.

KW - Gene therapy

KW - Leukemia

KW - Onco-suppressor

KW - Retroviral vector

KW - Tumor targeting

UR - http://www.scopus.com/inward/record.url?scp=0031450607&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031450607&partnerID=8YFLogxK

M3 - Article

C2 - 9472561

AN - SCOPUS:0031450607

VL - 4

SP - 1371

EP - 1378

JO - Gene Therapy

JF - Gene Therapy

SN - 0969-7128

IS - 12

ER -